What is CardioDex's primary business?

CardioDex develops, manufactures, and markets a disposable solution for closing arterial access sites following endovascular catheterization procedures. Its products expedite arterial closure through hemostasis without using glue, collagen, suturing, or other foreign materials.

When was CardioDex founded?

CardioDex was founded in January 2001.

What is the current status of CardioDex?

CardioDex is currently inactive, having ceased operations in February 2013.

Where is CardioDex headquartered?

CardioDex is headquartered in Caesarea, Center District, Israel.

What markets do CardioDex's products serve?

CardioDex's products are used in both diagnostic and therapeutic markets.

What is CardioDex's primary sector?

CardioDex's primary sector is Health Tech & Life Sciences.

CardioDex — Israeli Startup

About

CardioDex develops, manufactures, and markets a disposable solution for closing arterial access sites following endovascular catheterization procedures.CardioDex's products expedite arterial closure through hemostasis. Its closure device does not use glue, collagen, suturing, orother foreign materials that promote a clinical reaction, thus no residual material is deposited in the patient's body. The process relies on familiar balloon inflation/deflation techniques, which apply selective pressure precisely over the puncture site. The products do not require exchange of the introducer sheath. The company's products are used in diagnostic and therapeutic markets.

Q&A

What is CardioDex's primary business?: CardioDex develops, manufactures, and markets a disposable solution for closing arterial access sites following endovascular catheterization procedures. Its products expedite arterial closure through hemostasis without using glue, collagen, suturing, or other foreign materials.
When was CardioDex founded?: CardioDex was founded in January 2001.
What is the current status of CardioDex?: CardioDex is currently inactive, having ceased operations in February 2013.
Where is CardioDex headquartered?: CardioDex is headquartered in Caesarea, Center District, Israel.
What markets do CardioDex's products serve?: CardioDex's products are used in both diagnostic and therapeutic markets.
What is CardioDex's primary sector?: CardioDex's primary sector is Health Tech & Life Sciences.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Treatment & Therapeutics

Target customers

Healthcare & Life SciencesHealthcarePatientsLaboratoriesProviders

Business model

B2B

Founded	2001-1
Employees (exact)	6
Status reason	Non Active, Feb 2013 ceased to operate

CardioDex

About

Q&A

Sectors & technology

Tags

Identifiers & details

About

Q&A

Sectors & technology

Tags

Identifiers & details

Generate Slim Page